期刊文献+

Bcl-2基因表达抑制联合射线对NCI—H460细胞增殖状态及细胞周期影响的研究 被引量:3

To Explore the Activity of Generation and the Cell Cycle of NCI - H460 by RNAi Inhibiting Bcl - 2 Gene Expression and Combining Treatment with Radiation
下载PDF
导出
摘要 目的 利用RNAi技术抑制Bcl-2基因的表达,联合放疗后观察其对非小细胞肺癌NCI-H460株细胞周期及细胞增殖状态的影响.方法 利用以pCYU6/GFP/Neo为载体的Bcl-2/shRNA重组质粒转染非小细胞肺癌NCI-H460细胞株,采用Western blot方法检测Bcl-2基因蛋白表达水平的变化,继而给予直线加速器6Gy X线照射,采用MTT法和流式细胞术检测RNA干扰及照射后对NCI-H460细胞增殖和细胞周期的影响.结果 成功转染并经筛选获得阳性转染成功的细胞(HT),荧光显微镜下可见发绿色荧光的NCI-H460细胞,证明转染成功;Western blot检测显示Bcl-2蛋白表达水平显著降低;X线照射6Gy,24h及48h后转染有义序列组细胞增殖情况较无义序列组及未转染组明显降低;流式细胞术显示转染有义序列细胞组经照射后24小时G2/M期分布比例增高,48小时后G2/M期分布比例显著减低.结论 RNAi技术可以有效的抑制非小细胞肺癌NCI-H460细胞Bcl-2基因表达,联合放疗后NCI-H460细胞的增殖率及细胞周期发生改变,起到一定的放射增敏作用. Objective To explore the influence of Bcl - 2 gene expression by RNAi on cell cycle and activity of cell and the radiosensitivity of Non - Small cell lung cancer cell line NCI - 1-1460. Methods Making use of pCYU6/GFP/Neo on vectors containing shRNA targeting Bcl - 2 gene were transfeeted into NCI - H460. Western blot were used to compare the efficiency of gene silencing. The transfected cell were exposed to 6 Gy X - rays generated by a linear accelerator. MTT and Flow cytometry were used to explore the activity of generation and the cell cycle of NCI - H460. Results Bcl - 2/shRNA was successfully transfected NCI - I-I460 cell lines. Western blot analysis that expression of Bcl -2 was suppressed by Bcl -2/shRNA;The activity of generation of cells transfected with Bcl- 2/shRNA was lower than others at 6 Gy irradiation, and higher percentage of GJM phase was observed on cells transfected with Bcl -2/shRNA than others by cytometry. Conclusion RNAi could inhibit Bcl- 2 gene expression and enhance the activity of generation and the cell cycle of NCl - Hd60 cells.
出处 《实用肿瘤学杂志》 CAS 2012年第1期37-41,共5页 Practical Oncology Journal
基金 哈尔滨医科大学附属第三医院科研基金(JJ2008-09) 黑龙江省财政厅科研院所自拟课题(2009-07)
关键词 肺癌 BCL-2基因 RNA干扰 放射敏感性 细胞周期 Lung carcinoma Bcl - 2 gene RNA interference Cytometry
  • 相关文献

参考文献11

  • 1Huang Z.Bcl-2 family proteins as targets for anticancer drug design[J].Oncogene,2000,19(56):6627-6631.
  • 2Tse C,Shoemaker AR,Adickes J,et al.ABT-263:A potent and orally bioavailable Bcl-2 family inhibitor[J].Cancer Research,2008,68:3421-3428.
  • 3Cory S,Adams JM.The Bcl-2 family:regulators of the cellular life-or-death switch[J].Nat Rev Cancer,2002,2(9):647-656.
  • 4Richard J.Youle and Andreas Strasser.The Bcl-2 protein family:opposing activities that mediate cell death[J].Nat Rev Mol Cell Biol,2008,9:47-59.
  • 5JM Adams,S Cory.The Bcl-2 apoptotic switch in cancer development and therapy[J].Oncogene,2007,26(9):1324-1337.
  • 6Zhou BB,Elledge SJ.The DNA damage response:putting checkpoints in perspective[J].Nature,2000,408(6811):433-439.
  • 7Paull TT.New glimpses of an old machine[J].Cell,2001,107(5):563-565.
  • 8Lim DS,Kim ST,Xu B,et al.ATM Phosphorylates p95/nbsl in an S-phase checkpoint pathway[J].Nature,2000,404:613-617.
  • 9Durocher D,Jackson SP.DNA-PK,ATM and ATR as sensors of DNA damage:variations on a theme[J].Curr Opin cell Biol,2001,13(2):225-231.
  • 10Abrahsm RT.Cell cycle checkpoint sigaling through the ATM and ATR kinases[J].Genes,2001,15:2177-2196.

二级参考文献1

  • 1Zhou Jianfeng,Liu Wenli,Sun Lan,Sun Hanying,Tang Yi. Multiple defects of cell cycle checkpoints in U937-ASPI3K, an U937 cell mutant stably expressing anti-sense ATM gene cDNA[J] 2000,Journal of Tongji Medical University(4):273~276

共引文献12

同被引文献16

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部